By Dennis Thompson HealthDay ReporterTHURSDAY, March 12, 2026 (HealthDay News) — People frequently switch between different weight-loss drugs, swapping Ozempic for Zepbound and vice versa within the ...
Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now!
Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...
The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...
GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...
Broad use of a hormone prescribed for weight loss has spawned a flurry of menu items touted as “GLP-1 friendly,” but it’s phrase that has no strict definition.
New research suggests popular GLP-1 weight loss drugs like Ozempic, Wegovy, and Mounjaro may raise the risk of osteoporosis and gout. A large five-year study found slightly higher rates of bone ...
MedPage Today on MSN
GLP-1 Drugs May Prevent, Treat Multiple Addictions
Popular drug class quiets "drug noise," says researcher ...
Fact checked by Nick Blackmer New research suggests prolonged GLP-1 use may be linked to a higher risk of osteoporosis and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results